A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Applying to Ann & Robert H. Lurie Children's Hospital of Chicago (Adults and Pediatrics) · Chicago, Illinois
Answer a few short questions to share with the research team.